Guochen Song

MedicineMathematicsEconomics, Econometrics and FinanceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3”.

Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3

Neurology(2024)10.1212/wnl.0000000000209151

N/A

2.4DataRank · unranked

44 citations

Basil T. Darras, John Day, Sally Dunaway Young, Tina Duong, Leslie Nelson +14 more

Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?

UNC Libraries(2020)10.17615/xj2g-8d52

N/A

0DataRank · unranked

0 citations

Anastasia Ivanova, Christopher Jennison, Tom Parke, Inna Perevozskaya, Guochen Song +2 more

Enrollment and Stopping Rules for Managing Toxicity Requiring Long Follow-Up in Phase II Oncology Trials

UNC Libraries(2021)10.17615/aqep-1w54

N/A

0DataRank · unranked

0 citations

Guochen Song, Anastasia Ivanova

Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study

Frontiers in Neurology(2024)10.3389/fneur.2024.1419791

N/A

0DataRank · unranked

18 citations

John W. Day, Darryl C. De Vivo, Jena M. Krueger, Eugenio Mercuri, A. Nascimento +10 more